Comment: Reply to letter to the editor regarding the article "Anti-osteoporotic treatment after hip fracture remains alarmingly low".

This is a reply to the letter to the editor regarding the article "Anti-osteoporotic treatment after hip fracture remains alarmingly low" Dan Med J 2022;69(10):A01220010.

Anti-osteoporotic treatment after hip fracture remains alarmingly low.

Introduction: Osteoporosis and osteoporotic fractures typically affect postmenopausal women, and osteoporotic fractures significantly increase disability, morbidity and mortality. Several anti-osteoporotic agents are available and have been shown to effectively reduce the incidence of low-energy osteoporotic fractures. However, the post-osteoporotic fracture treatment rate remains low.

Prevalence of Mucopolysaccharidosis Types I, II, and VI in the Pediatric and Adult Population with Carpal Tunnel Syndrome (CTS). Retrospective and Prospective Analysis of Patients Treated for CTS.

Background: We wanted to investigate whether the prevalence of mucopolysaccharidoses (MPS) I, II, and VI was higher than expected in a selected cohort of patients with carpal tunnel syndrome (CTS). CTS is a common finding in patients with MPS, and therefore we screened patients who had undergone surgery for CTS for undiagnosed MPS.

Patients And Methods: Patients who had been operated for CTS were found in databases from two hospitals.